- Home
- NNVC vs TLPH Comparison
NNVC vs TLPH Comparison
Compare NNVC & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NNVC | TLPH |
|---|---|---|
| Founded | 2005 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.9M | 42.3M |
| IPO Year | 2008 | 2010 |
Fundamental Metrics
Financial Performance| Metric | NNVC | TLPH |
|---|---|---|
| Price | $1.75 | $1.29 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 349.7K | ★ 502.9K |
| Earning Date | 05-15-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,151,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.85 | $0.39 |
| 52 Week High | $2.23 | $1.57 |
Technical Indicators
Market Signals| Indicator | NNVC | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 61.20 | 59.61 |
| Support Level | $1.18 | $1.01 |
| Resistance Level | $1.90 | $1.29 |
| Average True Range (ATR) | 0.15 | 0.11 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 78.18 | 56.00 |
Price Performance
Historical ComparisonAbout NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.